- Home
- » Tags
- » Fluorometholone acetate
Top View
- PRODUCT CATALOGUE 2021 Available on Product Known Teva Tech US EU Japan Korea Therapeutic Api IP file*** DMF DMF DMF DMF Area**
- List of Off-Patent, Off-Exclusivity Drugs Without an Approved Generic
- BCBSNM/HMONM Therapeutic Class Drug List (Formulary) 2004
- Appendix B - Product Name Sorted by Applicant
- 2020 Drug Coverage
- PRODUCT MONOGRAPH Pr FLAREX7 Fluorometholone Acetate
- FY2019 GDUFA Science and Research Report
- Preferred Drug List Drug Class Review Announcement
- Combined Index to USP 41 and NF 36, Volumes 1–5, Including Second Supplement
- PBS List of Medicines Prescribed by Optometrists Revised November 2018
- Assessing the Extent of Evidence-Based Therapeutic Intervention in a University Based Family Medicine Outpatient Clinic
- Topical Corticosteroids (Cont.) Neuraminidase Inhibitors
- FML (Fluorometholone Ophthalmic Suspension
- Known Bioactive Library: Selleck Bioactive 10Mm, 3.33Mm, 1.11Mm
- Health Partners Medicaid
- (12) Patent Application Publication (10) Pub. No.: US 2002/0010208A1 Shashoua Et Al
- 4164-01-P Department of Health and Human Services
- Page 1 Consgrpdesc Itemno Unit 1003 VIAL 1005 AM/VI 1010 BOT 1020 BOT 1021 BOT 1022 BOT 1023 BOT 1024 BOT
- Combined Index to USP 42 and NF 37, Volumes 1–5, Including Second Supplement
- FEP 5 Tier Rx Drug Formulary (607) Standard Option
- List of Off-Patent, Off-Exclusivity Drugs Without an Approved Generic
- P&T Committee Meeting Minutes
- SFDA's Product Specific Bioequivalence Guidance
- List of Off-Patent, Off-Exclusivity Drugs Without an Approved Generic
- Appendix a - Product Name Index
- United States Patent (19) 11 Patent Number: 6,153,607 Pflugfelder Et Al
- Download API Catalog
- Wo 2007/044693 A2
- NSW 902 Contract Items with Substitution NSW 902 Contract Tender Product List with Replacements
- Preferred Drug List (PDL) Florida Healthy Kids Effective Date: 10/1/19
- Document Released
- In the Treatment of Ocular Surface Inflammation, FLAREX® Is a Proven
- January 13, 2020
- List of Off-Patent, Off-Exclusivity Drugs Without an Approved Generic
- Preferred Drug List (PDL) Arizona Effective Date: 1/1/2013
- 52:00 Eye, Ear, Nose and Throat (EENT) Preparations
- Supplementary Table 3
- 2016 CLINICAL GUIDE to OPHTHALMIC 20Th20thh Aanniversarynniversary DRUGS Eeditiondition
- FEP 5 Tier Managed Rx Drug Formulary (807) Basic Option
- Targeting APC Loss Using Synthetic Lethality in Colorectal Cancer
- Printed Formulary Catalog Basic
- WATSONS ONLINE STORE X BDO Exclusion List –Prescription Medicines BRAND PRODUCT NAME SUBCLASS NAME WATSONS Montelukast 10Mg 1
- Florida Healthy Kids Preferred Drug List
- Topical Ocular Therapeutic Pharmaceutical Agents Available in Canada 2013
- 2021 Formulary Kaiser Permanente a TRICARE® Prime Option
- Australian Product Information – Flarex (Fluorometholone Acetate) Eye Drops Suspension 1 Name of the Medicine
- Non-Preferred Drug List (NPDL) Effective Date: January 1, 2019
- Federal Register/Vol. 84, No. 226/Friday, November 22, 2019
- CLINICAL GUIDE to OPHTHALMIC DRUGS 21St21st Eeditiondition
- Navigating Q1/Q2 for Complex Generics
- Commercial Formulary
- Impact of Oncogene Expression in the Respiratory System of Drosophila
- WO 2007/016766 Al
- Therapeutic Class Overview Ophthalmic Steroids
- Therapeutic Drug Class